Search research articles
Contact Us
Filters
Showing results (571-580 of 715) with videos related to
Page
of 72
Sort By:
Gene Therapy
|
January 20, 2007
Species differences in transgene DNA uptake in hepatocytes after adenoviral transfer correlate with the size of endothelial fenestrae
J Snoeys, J Lievens, E Wisse, et al.
The Journal of Biological Chemistry
|
June 25, 1991
On the mechanism of fibrin-specific plasminogen activation by staphylokinase
H R Lijnen, B Van Hoef, F De Cock, et al.
Blood
|
August 1, 1996
Restoration of thrombolytic potential in plasminogen-deficient mice by bolus administration of plasminogen
H R Lijnen, P Carmeliet, A Bouché, et al.
Circulation
|
June 1, 1987
A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris
H K Gold, J A Johns, R C Leinbach, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 1, 2003
Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats
A Van Damme, M K L Chuah, F Dell'accio, et al.
Journal of the American College of Cardiology
|
March 1, 1987
Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction
H D Garabedian, H K Gold, R C Leinbach, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 14, 2000
Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis
B De Geest, D Stengel, M Landeloos, et al.
The Journal of Clinical Investigation
|
February 1, 1996
Generation and characterization of urokinase receptor-deficient mice
M Dewerchin, A V Nuffelen, G Wallays, et al.
Biochemistry
|
June 13, 1998
Arginine 719 in human plasminogen mediates formation of the staphylokinase:plasmin activator complex
L Jespers, N Van Herzeele, H R Lijnen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 14, 2004
Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice
M Dewerchin, L Van der Elst, I Singh, et al.
Page
of 72
Search research articles
Search
Showing results (571-580 of 715) with videos related to
Sort By:
Page
of 72
Gene Therapy
|
January 20, 2007
Species differences in transgene DNA uptake in hepatocytes after adenoviral transfer correlate with the size of endothelial fenestrae
J Snoeys, J Lievens, E Wisse, et al.
The Journal of Biological Chemistry
|
June 25, 1991
On the mechanism of fibrin-specific plasminogen activation by staphylokinase
H R Lijnen, B Van Hoef, F De Cock, et al.
Blood
|
August 1, 1996
Restoration of thrombolytic potential in plasminogen-deficient mice by bolus administration of plasminogen
H R Lijnen, P Carmeliet, A Bouché, et al.
Circulation
|
June 1, 1987
A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris
H K Gold, J A Johns, R C Leinbach, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
February 1, 2003
Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats
A Van Damme, M K L Chuah, F Dell'accio, et al.
Journal of the American College of Cardiology
|
March 1, 1987
Comparative properties of two clinical preparations of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction
H D Garabedian, H K Gold, R C Leinbach, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
October 14, 2000
Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis
B De Geest, D Stengel, M Landeloos, et al.
The Journal of Clinical Investigation
|
February 1, 1996
Generation and characterization of urokinase receptor-deficient mice
M Dewerchin, A V Nuffelen, G Wallays, et al.
Biochemistry
|
June 13, 1998
Arginine 719 in human plasminogen mediates formation of the staphylokinase:plasmin activator complex
L Jespers, N Van Herzeele, H R Lijnen, et al.
Journal of Thrombosis and Haemostasis : JTH
|
January 14, 2004
Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice
M Dewerchin, L Van der Elst, I Singh, et al.
Page
of 72